Response to Comment on: “Is Adjuvant Therapy a Better Option for Esophageal Squamous Cell Carcinoma Patients Treated With Esophagectomy? A Prognosis Prediction Model Based on Multicenter Real-world Data” : Annals of Surgery

Journal Logo

Advanced Search
Letters to the Editor

Response to Comment on: “Is Adjuvant Therapy a Better Option for Esophageal Squamous Cell Carcinoma Patients Treated With Esophagectomy? A Prognosis Prediction Model Based on Multicenter Real-world Data”

He, Zhonghu PhD*,; Liu, Fangfang PhD*; Yang, Wenlei PhD*; Ke, Yang MD*,

Author Information

*Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Genetics, Peking University Cancer Hospital & Institute, Beijing, People’s Republic of China

[email protected]

[email protected]

Annals of Surgery 276(6):p e1114-e1115, December 2022. | DOI: 10.1097/SLA.0000000000005281
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Full Text Access for Subscribers:

Not a Subscriber?

Buy
Request Permissions

You can read the full text of this article if you:

Access through Ovid